Interested in understanding the microscopy advances that lead to the 2014 Nobel Prize in Chemistry? Beyond the diffraction barrier is a new video overview of super-resolution microscopy strategies, by Andrew Q Tran, student in Biomedical Communication at University of Toronto. It explains techniques such as stimulated emission depletion (STED) microscopy, developed by 2014 Nobel prize winner Stefan Hell in 2000. Yves and Paul De Koninck and their teams at the Neurophotonics Centre collaborated to the making of this video. View it now: Beyond the diffraction barrier, an overview of super-resolution microscopy strategies
The Photonics games, organized to interest high school students to physics and photonics received important recognition recently.
The organizers of the games were honored with a prize at the Gala universitaire Forces AVENIR. Forces AVENIR is a non-profit organisation who aims to highlight student involvement. Read more about this in Le Fil.
The Quebec Chapter of the Society for Neuroscience is proud to announce that Simon Chamberland has won a travel award for the upcoming SfN meeting, November 15-19 in Washington, DC. The prize includes free registration to the meeting.
The research center of the Quebec Mental Health Institute (Institut universitaire en santé mentale de Québec - IUSMQ), in partnership with other Canadian institutions, will receive 3,3M$ from the Canadian Brain Research Fund to develop and manage the Canadian Neurophotonics Platform, over the next 3 years. The platform will be managed by the Research Centre of the IUSMQ, who will lead the initiative. The project aims to develop, test and promote new neurophotonics tools putting the power of optics and photonics to the service of neuroscience and brain research.
In a special section of the newspaper Le Devoir published for the 50 years of the "Fonds de Recherche du Québec - Santé", FRQS, Yves De Koninck explains the importance of this funding agency for Quebec researchers, and the advantage it gives then at the national and international level. Read the full article in the September 13 edition of Le Devoir (in French only): Le FRQS, un soutien essentiel pour les chercheurs
Listen to a recent interview with Jean-Martin Beaulieu, who recently won the 2014 IMHRO / Johnson & Johnson Rising Star Translational Research Award. He explains his research and his aim to develop safer, targeted mood stabilizing drugs by testing, in cell culture and in mice, small molecules which his past research suggests might replicate the therapeutic effect of lithium with minimal side effect.
The interview is available here: